Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Adaptimmune Therapeutics PLC ADR buy melinda

Adaptimmune Therapeutics PLC ADR
Start price
€5.62
02.12.18 / 50%
Target price
€10.82
22.01.19
Performance (%)
-25.52%
End price
€4.19
22.01.19
Summary
This prediction ended on 22.01.19 with a price of €4.19. The price of Adaptimmune Therapeutics PLC ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.52%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Adaptimmune Therapeutics PLC ADR -4.571% -4.571% 12.838% -81.362%
iShares Core DAX® 1.164% 1.549% 24.351% 23.659%
iShares Nasdaq 100 0.118% 0.969% 28.865% 41.786%
iShares Nikkei 225® 1.124% -1.120% 17.443% 6.454%
iShares S&P 500 0.479% 1.068% 28.585% 42.511%

Comments by melinda for this prediction

In the thread Adaptimmune Therapeutics PLC ADR diskutieren
Prediction Buy
Perf. (%) -25.52%
Target price 10.824
Change
Ends at 22.01.19

SecteurRecherche biotechnologique et médicale Agenda 13/03 Publication de résultats



métier
Logo Adaptimmune Therapeutics P
Fabrique des vaccins et des produits d'immunothérapie anticancéreuse

Adaptimmune Therapeutics Plc est une société biopharmaceutique au stade clinique spécialisée dans le développement de nouveaux produits d'immunothérapie anticancéreuse.

Sa plate-forme de récepteurs d’affinité à peptides améliorés permet à l’ingénierie des cellules T de cibler et de détruire le cancer, y compris les tumeurs solides.

La société a été créée le 3 décembre 2014 par Bent K. Jakobsen, James Julian Noble et Helena Katrina Tayton-Martin. Son siège social est situé à Abingdon, au Royaume-Uni.

Nombre d'employés  : 371 personnes.



melinda 
0
Report Share
02.12.18
Prediction Buy
Perf. (%) -25.52%
Target price 10.824
Change
Ends at 22.01.19

(Vom Mitglied beendet)

melinda 
0
Report Share
22.01.19

Stopped prediction by melinda for Adaptimmune Therapeutics PLC ADR

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€2.26
15.11.22
€3.50
15.11.23
-80.00%
16.11.23

melinda 
15.11.22 20%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.82
23.10.20
€5.00
04.11.21
15.71%
05.11.21

melinda 
23.10.20 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€7.35
25.08.20
-
23.10.20
-48.03%
23.10.20

melinda 
25.08.20 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€4.04
02.04.19
€4.51
30.10.19
-80.57%
30.10.19

melinda 
18.08.19 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€10.01
16.03.18
€13.53
19.04.18
12.16%
19.04.18

melinda 
18.08.19 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€6.13
27.12.17
€7.22
08.01.18
17.65%
08.01.18

melinda 
18.08.19 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€4.93
31.07.17
€5.41
28.08.17
9.69%
28.08.17

melinda 
14.08.19 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€5.47
31.07.17
€6.00
28.08.17
9.69%
28.08.17

melinda 
14.08.19 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€4.67
13.05.17
€5.32
17.05.17
5.98%
17.05.17

melinda 
14.08.19 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.88
09.03.17
€6.31
29.03.17
15.35%
29.03.17

melinda 
14.08.19 50%